Correlation Between Eyenovia and Bio Path

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Bio Path Holdings, you can compare the effects of market volatilities on Eyenovia and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Bio Path.

Diversification Opportunities for Eyenovia and Bio Path

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Eyenovia and Bio is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Eyenovia i.e., Eyenovia and Bio Path go up and down completely randomly.

Pair Corralation between Eyenovia and Bio Path

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Bio Path. In addition to that, Eyenovia is 3.79 times more volatile than Bio Path Holdings. It trades about -0.26 of its total potential returns per unit of risk. Bio Path Holdings is currently generating about -0.26 per unit of volatility. If you would invest  106.00  in Bio Path Holdings on August 30, 2024 and sell it today you would lose (29.00) from holding Bio Path Holdings or give up 27.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Bio Path Holdings

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Bio Path Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Eyenovia and Bio Path Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Bio Path

The main advantage of trading using opposite Eyenovia and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.
The idea behind Eyenovia and Bio Path Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets